Emergent BioSolutions Statistics
NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.07+0.12 (+1.73%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 7.19 +1.74%
Emergent BioSolutions by the numbers
Emergent BioSolutions has a market capitalization of $362.5 million based on 51.27M shares outstanding. With trailing EPS of $-3.40, Emergent BioSolutions is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.5% above its 50-day average and 17.3% below its 200-day average.
Average daily trading volume is 1.16M shares, or about $8.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EBS valuation vs. peer median
| Metric | EBS | Peer median | Difference |
|---|---|---|---|
| Market cap | $362.50M | $361.55M | +0% |
| Avg. volume | 1.16M | 663.32K | +74% |
Peer median across 8 companies: ENTA, ARCT, GALT, RLMD, IRD, TTRX, CYPH, BNTC.
Valuation
- Market cap
- $362.50M
- Forward P/E
- 6.76
- EPS (TTM)
- $-3.40
- Shares outstanding
- 51.27M
Price and trading
- Previous close
- 6.95
- Open
- 7.05
- Day range
- 6.86 – 7.35
- 52-week range
- 4.36 – 14.06
- Beta
- —
- Volume
- 1.23M
- Average volume
- 1.16M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 362.50M
- Forward Pe
- 6.76
- Eps
- -3.40
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.06
- Week52 Low
- 4.36
- Avg Volume
- 1.16M
- Shares Outstanding
- 51.27M
- Ma50
- 6.12
- Ma200
- 8.55
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -49.72%
- Pct From52w Low
- 62.16%